
Please try another search
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small cell lung cancer. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, a viral vaccine product candidate for targeting Cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.
Name | Age | Since | Title |
---|---|---|---|
Marianne Sogaard | 56 | 2020 | Independent Chairwoman of the Board |
Patrick Ott | - | - | Member of Advisory Board |
Christian Schilling | - | - | Member of Advisory Board |
Kirsten Aarup Drejer | 68 | 2021 | Member of Advisory Board |
Georgina Long | - | - | Member of Advisory Board |
Anthony Purcell | - | - | Member of Advisory Board |
Lars Aage-Staal Wegner | 50 | 2017 | Director |
Rajeev Surati | - | - | Member of Advisory Board |
Thomas Wylonis | - | - | Member of Advisory Board |
Roberto Prego Pineda | 55 | 2018 | Independent Director |
Jeffrey S. Weber | - | - | Member of Advisory Board |
Robert J. Palay | 68 | - | Member of Advisory Board |
Jürgen Langhärig | - | 2019 | Member of Advisory Board |
Andrew C. Webber | - | - | Member of Advisory Board |
Soren Brunak | - | - | Member of Advisory Board |
Michael W. Washabaugh | - | - | Member of Advisory Board |
Lars Holtug | 66 | 2021 | Independent Director |
Helen Tayton-Martin | - | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review